Biotech Phagos raises €25 Million to scale AI-Powered Alternatives to Antibiotics
Phagos, a Paris-based biotechnology company developing AI-driven bacteriophage therapies as sustainable alternatives to antibiotics, has raised €25 million in Series A funding.

The best Articles in our Network